Towards Inclusive and Equitable Clinical Trials

Clinical research is the foundation of medical progress. Every new medicine, treatment and innovation depends on clinical research and clinical trials. Yet for psoriasis and psoriatic arthritis—chronic, systemic diseases affecting more than 100 million people worldwide—many people living with these conditions remain underrepresented in clinical research and clinical trials.

People living with psoriatic disease represent every age, ethnicity and background, yet clinical trials do not always reflect this diversity. 

On the one hand, stigma, discrimination, practical barriers and misconceptions prevent many people from participating in research. On the other hand, the study design, protocol, and specific eligibility criteria exclude many who would benefit from the trial.  Building more inclusive clinical trials is essential to ensure that future treatments are safe, effective and relevant for everyone living with psoriatic disease.

IFPA invites you to join our two-part webinar series, Towards Inclusive and Equitable Clinical Trials, developed as part of the Breaking Barriers Project. Breaking Barriers is IFPA's global initiative, aimed to promote more inclusive and equitable clinical trials for people living with psoriatic disease.

 WEBINAR 1 

Clinical Trials Demystified

Everything You Wanted to Know About Clinical Trials (But Were Afraid to Ask)

September 18, 2026 | 10:00–11:00 CEST

Participants

• Professor Mahira El Sayed, Professor of Dermatology and Venereology, Board member, IPC (International Psoriasis Council)
• Keith Berelowitz, Founder and CEO of Trialport

Clinical trials can seem complicated or intimidating. Many people have questions about what participation actually involves, whether trials are safe, and who can take part.

In this webinar, we will separate myths from facts, explore how clinical trials are designed and regulated to protect participants, and discuss the barriers that continue to discourage many people from taking part in research.

Watch the recording of the webinar Clinical Trials Demystified:

 WEBINAR 2 

Until No One is Left Behind

From Barriers to Solutions: How Can We Make Clinical Trials More Inclusive?

September 22, 2026 | 15:00 CEST

Participants

• Robelle Tanangunan, Patient Representative, Philippines
• Jenny Garcia, Trial Equity Lead, Takeda, USA
• Cristina Marián Revilla, Clinical Project Manager, READI project, Spain

Only 3% of participants in major psoriasis clinical trials worldwide were Black. Who is still underrepresented in clinical research and why? 

In our second webinar, we will look at the barriers that prevent different populations from taking part in clinical trials and what can be done to remove them. From trial design and recruitment to accessibility and participation, the discussion will explore practical solutions for making clinical trials more inclusive and equitable.

Watch the recording of the webinar Until No One is Left Behind: